Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-World Study of Crisugabalin for Rosacea
NCT07606820Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Oct 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of crisugabalin besilate in rosacea (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Clinician's Erythema Assessment at 4 weeks. Started Oct 2025; status: completed.
02
Drugs
crisugabalin besilate
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT07606820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07606820.